These differences in the response of EBV-specific CD4 T cells in patients with SLE may be due to the use of different periods of stimulation (6 h versus 24 h between Kang et al. and Cassaniti et al.)and/or the EBV-specific antigens used [104,110]. The gene discussed is CD4; the disease is systemic lupus erythematosus.